“An era of industrialized, reproducible platform gene therapy manufacturing is in sight but will require change.”
No takes yet. Share an insight, caveat, or question.
Toby Gamlen (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: